8 results
20-F
2018 FY
EX-2.3
AUTL
Autolus Therapeutics plc
23 Nov 18
Annual report (foreign)
12:00am
controversy that might arise with respect to the interpretation or implementation of this Section 2.
(b) It shall be a condition precedent
F-1
EX-10.2
AUTL
Autolus Therapeutics plc
7 May 18
Registration statement (foreign)
4:45pm
of the jurisdiction in which such Intellectual Property applies.
19.2Dispute Resolution Procedures. Should any dispute, claim or controversy arise between
F-1/A
EX-10.2
AUTL
Autolus Therapeutics plc
10 May 18
Registration statement (foreign) (amended)
5:19pm
such Intellectual Property applies.
19.2Dispute Resolution Procedures. Should any dispute, claim or controversy arise between the Parties relating
F-1/A
EX-10.2
AUTL
Autolus Therapeutics plc
8 Jun 18
Registration statement (foreign) (amended)
6:25am
applies.
19.2Dispute Resolution Procedures. Should any dispute, claim or controversy arise between the Parties relating to the validity, interpretation
F-1
EX-10.1
uto21ab1
7 May 18
Registration statement (foreign)
4:45pm
F-1/A
EX-10.1
rjjrwjm7fw4
10 May 18
Registration statement (foreign) (amended)
5:19pm
10-K
EX-10.12
5sqg91ivigeb k3og
21 Mar 24
Annual report
4:55pm
- Prev
- 1
- Next